1-8 of 8
Shraga Aviner
Close
Sort by
Journal Articles

Universal Screening for G6PD Deficiency Detects More Cases Than Selective Testing

Ilan Segal, MD, Shraga Aviner, MD PhD, Ashraf Abu Rmaileh, MD, Ornit Cohen, Msc, Avraham Sayag, MD, Shmuel Zangen, MD
Journal: Blood
Blood (2016) 128 (22): 1261.
https://doi.org/10.1182/blood.V128.22.1261.1261
Published: 2016
Journal Articles

Persistent neonatal thrombocytopenia can be caused by IgA antiplatelet antibodies in breast milk of immune thrombocytopenic mothers

Clinical Trials & Observations Brief Report
Hagit Hauschner, Nurit Rosenberg, Uri Seligsohn, Rafael Mendelsohn, Aryeh Simmonds, Yakov Shiff, Yaakov Schachter, Shraga Aviner, Nechama Sharon
Journal: Blood
Blood (2015) 126 (5): 661–664.
https://doi.org/10.1182/blood-2014-12-614446
Published: 2015
Includes: Supplemental data
Journal Articles

Mycoplasma Pneumonia Infection - a Possible unrecognized Cause for Immune Thrombocytopenic Purpura

Shraga Aviner, MD, PhD, Daniel London, MD, Shulamith Horowitz, PhD, Menachem Schlesinger, MD, Gilles Lugassy, MD
Journal: Blood
Blood (2008) 112 (11): 4555.
https://doi.org/10.1182/blood.V112.11.4555.4555
Published: 2008
Journal Articles

Spontaneous Resolution of Extreme Essential Thrombocytosis in a Child

Shraga Aviner, MD, PhD, Menachem Schlesinger, MD, Gilles Lugassy, MD
Journal: Blood
Blood (2008) 112 (11): 4563.
https://doi.org/10.1182/blood.V112.11.4563.4563
Published: 2008
Journal Articles

Frequency and Natural History of Inherited Bone Marrow Failure Syndromes: The Israeli Inherited Bone Marrow Failure Registry

Hannah Tamary, MD, Daniella Nishri, MD, Joanne Yacobovich, MD, Rama Zilber, RN, Shraga Aviner, MD, PhD, Polina Stepensky, MD, Shoshana S Vilk- Ravel, Menachem Bitan, Chaim Kaplinsky, MD, Ayelet Ben Barak, MD, Joseph Kapelusnik, MD, Ariel Koren, MD, Carina Levin, MD, Isaac Yaniv, MD, Philip S Rosenberg, PhD, Blanche P. Alter, MD
Journal: Blood
Blood (2008) 112 (11): 1045.
https://doi.org/10.1182/blood.V112.11.1045.1045
Published: 2008
Journal Articles

Eradication of B Cell Malignancies by Anti-3 rd Party CTLs: A Novel Role for MHC Class I.

Assaf Lask, MSc, Polina Goichberg, PhD, Rinat Goren-Arbel, PhD, Oren Milstein, MSc, Shraga Aviner, MD, Ilan Feine, Tirza Klein, PhD, Alain Berrebi, MD, Yair Reisner, PhD
Journal: Blood
Blood (2007) 110 (11): 2759.
https://doi.org/10.1182/blood.V110.11.2759.2759
Published: 2007
Journal Articles

Eradication of B-CLL by autologous and allogeneic host nonreactive anti–third-party CTLs

Fabian D. Arditti, Shraga Aviner, Benjamin Dekel, Rita Krauthgamer, Judith Gan, Arnon Nagler, Antonio Tabilio, Massimo Martelli, Alain Berrebi, Yair Reisner
Journal: Blood
Blood (2005) 105 (8): 3365–3371.
https://doi.org/10.1182/blood-2003-03-0982
Published: 2005
Journal Articles

Eradication of B-Lymphoma by Allogeneic Anti-Third Party Host Non-Reactive CTLs: Growing Evidence for TCR Independent Reactivity Against B-Cell Malignancies.

Shraga Aviner, MD, Fabian D. Arditti, PhD, Rinat Arbel-Goren, PhD, Tirza Klein, PhD, Yair Reisner, PhD
Journal: Blood
Blood (2004) 104 (11): 3055.
https://doi.org/10.1182/blood.V104.11.3055.3055
Published: 2004